Valuation: Prenetics Global Limited

Market Cap 272M 242M 221M 202M 380M 25.67B 390M 2.66B 1.06B 13.6B 1.02B 998M 42.91B P/E 2026 *
-4.67x
P/E 2027 * -11.3x
Enterprise Value 272M 242M 221M 202M 380M 25.67B 390M 2.66B 1.06B 13.6B 1.02B 998M 42.91B EV / Sales 2026 *
1.21x
EV / Sales 2027 * 0.67x
Free-Float
81.76%
Yield 2026 *
-
Yield 2027 * -
1 day+1.71%
1 week-14.38%
Current month-8.50%
1 month-22.47%
3 months-11.97%
6 months-2.87%
Current year+3.17%
1 week 14.69
Extreme 14.69
18.89
1 month 14.69
Extreme 14.69
23.15
Current year 14
Extreme 14
27.24
1 year 11.36
Extreme 11.365
27.24
3 years 2.85
Extreme 2.85
27.24
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 2013-12-31
Chief Executive Officer 47 2013-12-31
Director of Finance/CFO 41 2017-12-31
Director TitleAgeSince
Chairman 47 2013-12-31
Director/Board Member 38 -
Director/Board Member - 2026-02-15
Date Insider Type Main position Quantity % Market Cap. Importance
10/4/26 Exercice

Director

4,000 0.0257%
9/30/26 Exercice

Chief Financial Officer

15,270 0.0981%
9/4/26 Exercice

Director

4,000 0.0257%
Change 5-day change 1-year change 3-year change Capi.($)
+1.71%-14.38%+27.75%+237.28% 272M
-1.81%+8.24%-9.12%+19.14% 200B
-0.60%+7.24%+15.20%+41.84% 128B
-1.57%+6.90%-6.83%+20.38% 129B
+1.51%+7.72%-39.31%+11.17% 97.53B
-3.33%+3.88%-3.01%+74.39% 67.55B
+1.22%+6.27%+19.49%-18.65% 56.98B
-3.61%+16.50%-6.83%+58.62% 55.04B
-1.39%-8.86%-4.24%+57.30% 51.24B
-0.79%+6.84%+4.91%-5.85% 37.43B
Average -0.85%+6.62%-0.20%+49.56% 82.37B
Weighted average by Cap. -1.15%+9.78%-4.95%+27.80%

Financials

2026 *2027 *
Net sales 224M 200M 183M 166M 314M 21.2B 322M 2.2B 878M 11.22B 842M 824M 35.42B 404M 360M 330M 300M 566M 38.21B 581M 3.96B 1.58B 20.23B 1.52B 1.48B 63.85B
Net income -60.77M -54.15M -49.53M -45.11M -85.03M -5.74B -87.32M -595M -238M -3.04B -228M -223M -9.6B -24.39M -21.73M -19.88M -18.1M -34.13M -2.3B -35.05M -239M -95.5M -1.22B -91.55M -89.58M -3.85B
Net Debt - -
Projected Income Statement - Annual - Prenetics Global Limited
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
26-11-05 $16.25 +1.31% 313,989
26-11-04 $16.04 -0.93% 174,732
26-11-03 $16.19 -1.70% 92,399
26-11-02 $16.47 -7.26% 266,265
26-10-30 $17.76 -6.43% 101,853
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Prenetics Global Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
16.04USD
Average target price
38.44USD
Spread / Average Target
+139.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Prenetics Global Limited